Marshall Wace North America’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$214M Buy
1,045,327
+140,650
+16% +$30.1M 0.91% 14
2021
Q2
$187M Buy
904,677
+377,236
+72% +$76M 0.78% 14
2021
Q1
$100M Buy
527,441
+521,647
+9,003% +$96.8M 0.42% 52
2020
Q4
$1.1M Buy
+5,794
New +$1.08M ﹤0.01% 923
2020
Q1
Sell
-300,985
Closed -$45.9M 1578
2019
Q4
$45.9M Buy
300,985
+78,422
+35% +$11.5M 0.22% 125
2019
Q3
$32.2M Buy
222,563
+18,010
+9% +$2.69M 0.18% 130
2019
Q2
$30.5M Buy
+204,553
New +$27.3M 0.19% 120

Other funds holding STE

Marshall Wace North America's STE Position: Q3 2021 in Review

Marshall Wace North America increased its Steris (STE) stake by 16% in Q3 2021, buying an estimated $30.1M and bringing the position to 1,045,327 shares worth $214M. The position accounts for 0.91% of the portfolio, ranked #14.

Marshall Wace North America first reported a position in STE in Q2 2019 and has held it in 7 quarters since. 629 funds tracked by Wall St. Rank hold STE as of Q3 2021.

  • Marshall Wace North America held 1,045,327 shares of Steris worth $214M as of Q3 2021.
  • Marshall Wace North America bought 140,650 Steris shares in Q3 2021, an estimated $30.1M.
  • Steris made up 0.91% of Marshall Wace North America's portfolio in Q3 2021, its #14 holding.
  • Marshall Wace North America first reported a position in Steris in Q2 2019 and has held it in 7 quarters since.
  • 629 funds tracked by Wall St. Rank held Steris as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.